Our research is aimed at understanding the molecular and cellular processes underlying human health and disease with a key aim to translate this research into diagnostic and therapeutic applications. Investment in state-of-the-art genomic and proteomic technologies has allowed a systems-led approach to explore the interacting networks of genes, molecules and cells underpinning disease processes. Our research in Diagnostics utilises interdisciplinary approaches to identify novel molecular disease markers and therapies. The major research themes are:
Professor Simon Jackson, Centre Director
Mat Upton, along with collaborators, has just been awarded £933k from Innovate UK to help take his discoveries of new antibiotic molecules towards drug therapy. He has also been awarded £33k by Innovate UK to develop a test for microbial pathogens as part of another consortium investigating the environmental dangers of ship's ballast.
Xinzhong Li has set up a large multidisciplinary and international team to train 14 PhD students while developing new approaches to brain cancer diagnosis (with Electrical Engineering and Business collaborators here at Plymouth University). The EU Horizon 2020 committee has announced a €3.7 million award to support this project.
Michael Jarvis is working with virologists at Oxford to find a vaccine for Hepatitis C; they have just been awarded a grant for this work from the Medical Research Council.
The children's charity Action Medical Research has awarded Sylwia Ammoun £65,000 to support her work on drug therapies for Merlin-deficient tumours. Read the Action Medical Research article for details.
Read older news
Plymouth University Peninsula Schools of Medicine and Dentistry (PU PSMD)
Hands on learning, exceptional partnerships and patient-focused research. Train with us to be a doctor, dentist or medical researcher of tomorrow.Discover more about the Plymouth University Peninsula Schools of Medicine and Dentistry (PU PSMD)